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Abstract
Background: Prolactin-related proteins (PRPs) are specific proteins of the growth hormone/
prolactin (GH/PRL) family in bovine placenta. This study reports the identification and sequencing
of a full-length cDNA for two new members of bovine PRPs, bPRP-VIII and -IX, and their
localization and quantitative expression in bovine placenta.
Methods: New bPRP-VIII and -IX were identified from bovine placentome. Localization and
quantitative gene expression in the placenta were respectively investigated by in situ hybridization
and real-time RT-PCR methods. Recombinant proteins of these genes were produced by a
mammalian HEK293 cell expression system.
Results:  Full-length bPRP-VIII and -IX cDNA were respectively cloned with 909 and 910
nucleotide open-reading-frames corresponding to proteins of 236 and 238 amino acids. The
predicted bPRP-VIII amino acid sequence shared about 40 to 70% homology with other bPRPs, and
bPRP-IX had about 50 to 80 % homology of others. The two new bPRPs were detected only in the
placenta by RT-PCR. mRNA was primarily expressed in the cotyledon and intercotyledonary
tissues throughout gestation. An in situ hybridization analysis revealed the presence of bPRP-VIII
and -IX mRNA in the trophoblastic binucleate and/or trinucleate cells. bPRP-VIII mRNA was
observed in the extra-embryonic membrane on Day 27 of gestation, however, no bPRP-IX mRNA
was observed in the extra-embryonic membrane in the same stage of pregnancy by quantitative
real-time RT-PCR analysis. Both new bPRP genes were possible to translate a mature protein in a
mammalian cell expression system with approximately 28 kDa in bPRP-VIII and 38 kDa in bPRP-IX.
Conclusion: We identified the new members of bovine prolactin-related protein, bPRP-VIII and -
IX. Localization and quantitative expression were confirmed in bovine placenta by in situ
hybridization or real-time PCR. Their different temporal and spatial expressions suggest a different
role for these genes in bovine placenta during gestation.
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Background
Prolactin-related proteins (PRPs) are members of the
growth hormone/prolactin (GH/PRL) family [1]. PRPs are
highly expressed in binucleate cells of bovine trophob-
lasts, although their function is still obscure. No new
member had been identified between early 1990 and this
year [2]. We recently found a new PRP member through a
comprehensive analysis using a bovine utero-placental
cDNA microarray [3]. Seven bovine PRP  (bPRP) genes
have been identified in placentomal tissues, whereas only
two of those genes have been shown to be translated. The
expression pattern of these genes is spatially and tempo-
rally different. bPRP-I indicates the considerable impor-
tance of regulation of implantation and formation of the
placentome in bovines [4,5]. However, bPRP-VII  was
expressed in intercotyledon and cotyledon with rather
weak compare to those of bPRP-I during the gestation [6].
Placental lactogens (PLs) are known as classical members
and PRPs are categorized as the non-classical members of
the GH/PRL family in bovine [7]. Various non-classical
members are common in rodents, such as mice and rats,
and some of them exhibit known biological functions,
such as proliferin and prolactin-like protein-A (PLP-A) [7-
12]. However, as a whole the biological function of Prol-
actin-related genes is still not known in various species
including bovine. Two research groups identified bovine
PRPs mRNA individually; bPRP-I to -III were identified by
the Schuler group [13,14], and bPRP-IV to -VI were iden-
tified by the Nakashima group [15-17]. We recently iden-
tified another one named as bPRP-VII [6]. Our previous
study suggested our bovine placental cDNA library con-
tained other bPRP genes [3]. We reveal here the full-length
sequences of two new members of bPRPs, bPRP-VIII and -
IX, and their localization and quantitative expression. We
confirmed the possibility of translation of them and the
accuracy of these gene sequences to produce a recom-
binant protein using the HEK293 cell-transfecting system.
Materials and methods
Animals and tissues
Placental tissues for cDNA cloning and mRNA expression
were collected from Japanese Black cows. The extra-
embryonic tissues, placenta, and endometrium were col-
lected at a local slaughterhouse on days 27 to 28, 56 to 64,
144 to 149, and 245 to 258 after artificial insemination
(day 1). The tissues were separated into four portions: the
cotyledon (COT); intercotyledon (the area between the
cotyledonary villous (ICOT)); the caruncle area, including
the maternal placentomal septa in the endometrium
(CAR); and the intercaruncle area (ICAR). It was difficult
to divide the COT and ICOT on days 27 to 28, and thus
the COT contained very few villi. Tissues from two differ-
ent cows on day 27 and one cow on day 28 of gestation (n
= 3) were used as Day 27 extra-embryonic membrane
(Day 27EEM), Day 27 caruncle (Day 27CAR), and Day 27
intercaruncular endometrium (Day 27ICAR). Placen-
tomal tissues were collected on days 56, 58, and 64 (in
total, n = 3) and designated as Day 60COT, CAR, ICOT,
and ICAR. Sample materials from days 144, 148, and 149
(n = 3) and days 245 (two samples) and 252 (one sample)
were marked as Day 150COT, CAR, ICOT, ICAR, Day
250COT, CAR, ICOT, and ICAR. The cotyledonary and
caruncular part was separated mechanically, and each part
may contained a counter part of tissue. The collected sam-
ples were stored at -80°C until RNA extraction. The pla-
centomes of day 60 were fixed in 3.7% formaldehyde PBS
at pH 7.4 and then embedded in paraffin wax and stored
at 4°C until in situ hybridization. All procedures for these
animal experiments were carried out in accordance with
the guidelines and ethics approved by the Animal Ethics
Committee of the National Institute of Agrobiological Sci-
ences for the use of animals.
Cloning of full-length bPRP-VIII and -IX cDNA
The new full-length bPRP-VIII and -IX cDNA were isolated
from bovine cotyledonary tissue by the 3'-rapid amplifica-
tion of cDNA ends (RACE) method. In brief, a complete
RNA was isolated from a bovine placentome on day 60 of
gestation using ISOGEN (Nippon Gene, Toyama, Japan).
We performed 3'-RACE using a 3'-full RACE core set
(Takara, Kyoto, Japan) with bPRP-VIII-specific forward
primer (5'-CCACAGTCAACAGGAGTCCTCA-3') and
bPRP-IX-specific forward primer (5'-CCAACAGAGAGTC-
CTCACCCTGCGA-3'). The bPRP-VIII and -IX primer was
designed from bovine EST accession number AW464912
and BP108069, respectively. The 3'-RACE products were
sequenced using an ABI Prism 370 automatic sequencer
(Applied Biosystems, Foster City, CA, USA) after cloning
into a pGEM-T Easy vector (Promega, Madison, WI, USA).
Phylogenetic analysis
Alignments of deduced protein sequences were performed
with the multiple alignment software Clustal W 1.83 on
the DDBJ web site. Clustal W was also employed to calcu-
late trees using the Neighbor-Joining (NJ) method [18].
TreeView was used to display the phylogenetic tree [19].
The values represent bootstrap scores for 1,000 trials, indi-
cating the credibility of each branch. Except the bPRP-VIII
and -IX sequences, all the bPRPs and bPLs protein
sequences were obtained from GenBank. Their GenBank
accession numbers are: bPRP-I (J02944), bPRP-II
(M27239), bPRP-III (M27240), bPRP-IV (M33269),
bPRP-V (AB239755), bPRP-VI (X59504), bPRP-VII
(AB187564), bPL-Ala (J02840), and bPL-Val (M33268).
Three-dimensional structure prediction by FAMS
We predicted the three-dimensional (3D) structure of
bPRP-VIII and -IX by using the FAMS (Fully automated
homology modeling system; http://www.pharm.kitasato-Reproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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Nucleotide and deduced amino acid sequences of bPRP-VIII Figure 1
Nucleotide and deduced amino acid sequences of bPRP-VIII. The arrow indicates the putative primary cleavage site of 
the signal peptide. The potential N-glycosylation site is underlined with a dotted line. The asterisks indicate the termination 
codon. The polyadenylation signal is underlined with a solid line.
                                     1                                           46 
                                     CCACAGTCAACAGGAGTCCTCACCCTGGGATCATTCCACAATCCCC 
    47                                                                          106 
    ATG GCT CCA GCT CCC AGC TTC TGT GGA CAC CAG TGG ACT TAC AAC CCT GTC CAA GGG TCC 
    Met Ala Pro Ala Pro Ser Phe Cys Gly His Gln Trp Thr Tyr Asn Pro Val Gln Gly Ser 
    1                                                                            20 
    107                                                                         166 
    TGC CTG CTG CTG CTG CTG GTC ATG TCA AAT CTG CTC CTG TGC CAA GGC AGA ACA TGC CCG 
    Cys Leu Leu Leu Leu Leu Val Met Ser Asn Leu Leu Leu Cys Gln Gly Arg Thr Cys Pro 
    21                                                                           40 
    167                                                                         226 
    TTC TGC TGT TCT GAC GTG TTT GAC ATC CCC TTG GAA TCC CTT AGA AAC CTG TTT CTC AAT 
    Phe Cys Cys Ser Asp Val Phe Asp Ile Pro Leu Glu Ser Leu Arg Asn Leu Phe Leu Asn
    41                                                                           60 
    227                                                                         286 
    GCT ACC ATG TTG TCC CGC GAC ATT GCC ATC CAT TCC AGC ATA ATG TTC ACT GAT TTT GAT 
    Ala Thr Met Leu Ser Arg Asp Ile Ala Ile His Ser Ser Ile Met Phe Thr Asp Phe Asp 
    61                                                                           80 
    287                                                                         346 
    GAA AAA TAT GCC CAG GGC AAA CAG TAC GAT ATC AAT GAC AAG AGC TGC CAT ACC GAT CCC 
    Glu Lys Tyr Ala Gln Gly Lys Gln Tyr Asp Ile Asn Asp Lys Ser Cys His Thr Asp Pro 
    81                                                                          100 
    347                                                                         406 
    CTC CCT ACT CCC GAA GAA AGA GAA CAA GCC CTA AAG ATA AAC AAT GAA GAC CTG AGT AAG 
    Leu Pro Thr Pro Glu Glu Arg Glu Gln Ala Leu Lys Ile Asn Asn Glu Asp Leu Ser Lys 
    101                                                                         120 
    407                                                                         466 
    TGG ATA ATC ATG TTA CTG TAC TCC TGG AAA AGA CCT CTA AAT CAT CTA GTC ACA GAG CTG 
    Trp Ile Ile Met Leu Leu Tyr Ser Trp Lys Arg Pro Leu Asn His Leu Val Thr Glu Leu 
    121                                                                         140 
    467                                                                         526 
    CAG AAT ATG AAA GAA GTC TCA GAT ACT ATC CTA TCA AGT GCC AGA CAA AAT TTG AAA AAA 
    Gln Asn Met Lys Glu Val Ser Asp Thr Ile Leu Ser Ser Ala Arg Gln Asn Leu Lys Lys 
    141                                                                         160 
    527                                                                         586 
    GTA CAA GAA CTT CAA GAA TTC ATA GAG AGG CAA TTC AGC CAG ATT ATT TTT CCA GTA AGG 
    Val Gln Glu Leu Gln Glu Phe Ile Glu Arg Gln Phe Ser Gln Ile Ile Phe Pro Val Arg 
    161                                                                         180 
    587                                                                         646 
    CGG CTG ACC GAG GGT GAA ATA GTC TGG TCA GAA CTT CCA TCC CTG GTG TCC AGC GAT GAA 
    Arg Leu Thr Glu Gly Glu Ile Val Trp Ser Glu Leu Pro Ser Leu Val Ser Ser Asp Glu 
    181                                                                         200 
    647                                                                         706 
    GAT ATT CGT CAT TCT GCA TTT TAT AAC CTG TTC AAG TGC CTG CAG AGG GAT TCA CAT AAA 
    Asp Ile Arg His Ser Ala Phe Tyr Asn Leu Phe Lys Cys Leu Gln Arg Asp Ser His Lys 
    201                                                                         220 
    707                                                             757 
    GTT GAC ATG TAC ACC AAG ATC ATG TTG TGC CGA ATC AAC AAC ACG TGC TAA 
    Val Asp Met Tyr Thr Lys Ile Met Leu Cys Arg Ile Asn Asn Thr Cys *** 
    221                                                         236 
    758                                                                         836 
    ATCCAAAGCATCCCATCCAGCTCTGAGGTGGTGGTAATGTTCTATCCCATAGCAAGCTTCTTAGAAATTTATAGTTTTT 
    837                                                                906
    TAATGCATGCTCTGTGAAATGGGTCTCCTCTAAAAAAATAAACACAGACTCTGTAGAAAAAAAAAAAAAAReproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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u.ac.jp/fams/index.html) [20]. FAMS is the software
which predicts 3D model of the target protein from the
structural known protein of high homology. In case of
bPRP-VIII and -IX, the 3D structure was constructed based
on the human prolactin (hPRL) 3D structure (Protein
Data Bank ID: 1N9D) in the element. FAMS program only
requires an amino acids sequence as input, and constructs
3D model structures automatically. Visualization of the
3D structure was performed using the RasMol 2.7.3 soft-
ware http://www.bernstein-plus-sons.com/software/ras
mol/[21].
RT-PCR
Tissue distribution of bPRP-VIII and -IX expression was
studied by RT-PCR. Bovine GAPDH was used as a positive
control for the PCR. Details of the RT-PCR method were
described in previous reports [6,22]. The total RNA in a
total reaction mixture was used for reverse transcription
and template cDNA synthesis using oligo(dT) primer and
Superscript II reverse transcriptase (Invitrogen, Carlsbad,
CA, USA) at 42°C for 50 min. Each PCR contained the
cDNA template, primers, deoxynucleotide triphosphate
mixture (dNTP), MgCl2, 10 × PCR buffer II, autoclaved
milliQ water, and AmpliTaq gold DNA polymerase
(Applied Biosystems). Amplification conditions included
denaturation at 95°C for 30 sec and extension at 72°C for
1 min. Twenty-seven cycles were performed for all sam-
ples. The annealing temperature was set at 60°C for 30
sec. A single denaturation step at 95°C for 10 min before
the first PCR cycle and a final extension step at 72°C for
10 min after the last PCR cycle were also performed. The
PCR products were analyzed by agarose gel electrophore-
sis and visualized by ethidium bromide staining. The
primers encoding for the bPRP-VIII and -IX sequences
were designed using the sequence illustrated in Fig. 1. The
primer sequence was selected to include a mismatch for
other bPRPs. The designated primers are listed in Table 1.
All the primers were commercially synthesized (Espec
Oligo Service, Tsukuba, Japan).
In situ hybridization
Full-length cDNA of bPRP-VIII and -IX was used as a tem-
plate for hybridization probe synthesis. Digoxigenin
(DIG)-labeled antisense and sense-complementary RNA
probes were prepared as described in previous studies
[6,23]. The placentomes were sectioned into 7 µm-thick
sections for hybridization. In situ hybridization was per-
formed using automated Ventana HX System Discovery
with a RiboMapKit and BlueMapKit (Ventana, Tucson,
AZ, USA) [6]. Briefly, sections were hybridized with DIG-
labeled probes in RiboHybe (Ventana) hybridization
solution at 65°C for 6 hours. The sections were washed
three times in RiboWash (Ventana) (65°C, 6 min) after
hybridization and were fixed in RiboFix (Ventana) (37°C,
10 min). The hybridization signals were then detected
with monoclonal-anti-digoxin biotin conjugate (Sigma,
Saint Louis, MI, USA). The hybridized glasses were
observed after preparation with a Nikon ECLIPSE E800
photomicroscope (Nikon, Tokyo, Japan).
Real-time RT-PCR
Gene expression of bPRP-VIII and -IX was confirmed
quantitatively at each stage of gestation (Days 27FM,
27CAR, 27ICAR, 60COT, 60CAR, 60ICOT, 60ICAR,
150COT, 150CAR, 150ICOT, 150ICAR, 250COT,
250CAR, 250ICOT, and 250ICAR) by real-time RT-PCR
analysis. Details of the real-time RT-PCR procedures have
been described in previous reports [6,24]. Briefly, fifty ng
of the total RNA were reverse transcribed into cDNA for 30
min at 48°C by MultiScribe™ reverse transcriptase with an
Oligo dT primer, dNTP mixture, MgCl2 and RNase inhib-
itor. Primer pairs and oligonucleotide probes labeled with
a reporter fluorescent dye at the 5'-end and a quencher flu-
orescent dye at the 3'-end were designed using the Primer
Express computer software program (Applied Biosys-
tems). The primers and probes for each gene are listed in
Table 2. The thermal-cycling conditions included initial
sample incubation at 50°C for 2 min and at 95°C for 10
min, followed by 40 cycles at 95°C for 15 sec and at 60°C
for 1 min. The cycle threshold values (CT) indicate the
quantity of the target gene in each sample and were deter-
mined in real time using an ABI Prism 7700 sequence
detector (Applied Biosystems). The relative difference in
the initial amount of each mRNA species (or cDNA) was
determined by comparing the CT values. The standard
curves for each gene were generated by serial dilution of
plasmid containing bPRP-VIII, -IX, or GAPDH cDNA to
quantify the mRNA concentrations. The ratio of bPRP-VIII
Table 1: Oligonucleotide primers used for RT-PCR
Gene Primer Sequence Position
bPRP-VIII Forward 5'-AGAACATGCCCGTTCTGCTGT-3' 155–175
(AB196438) Reverse 5'-TTAGCACGTGTTGTTGATTCG-3' 757-737
bPRP-IX Forward 5'-AACTCATGCCCATCCTGTGGT-3' 150–170
(AB204881) Reverse 5'-TTAGCACTTTTTGCGGATTCG-3' 758-738
GAPDH Forward 5'-CCTTCATTGACCTTCACTACATGGTCTA-3' 71–98
(U85042) Reverse 5'-GCTGTAGCCAAATTCATTGTCGTACCA-3' 927-901Reproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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and -IX mRNA to GAPDH mRNA was calculated to adjust
for any variations in the RT-PCR reaction. All values are
presented as mean ± SD. Statistical analysis was per-
formed using one-way ANOVA followed by the Tukey-
Kramer multiple comparison test. Differences were con-
sidered significant at P < 0.05.
Production of recombinant proteins
The bPRP-I, -VIII, -IX, and bPL sequences encoding the
mature protein region, which combined the FLAG and 6 ×
His epitope tag sequences, were inserted into the pFLAG-
CMV-3 vector (Sigma). The constructed plasmid was
transfected into HEK 293 cells using FuGENE 6 (Roche
Diagnostics, Basel, Switzerland) for transient transfection.
Stably transfected HEK 293 cells were adapted to the sus-
pension culture in a spinner flask using 293 SFM II
medium (Invitrogen, Gibco) and cultured in an atmos-
phere of 5% CO2 in air at 37°C for 3 days. The medium
was separated by centrifugation and stored at -30°C.
Western blot analysis
The 10 µg of proteins from the HEK293 cell conditioned
media were loaded on each lane, separated by SDS-PAGE,
and electrophoretically transferred onto a polyvinylidene
difluoride membrane [25]. Western blotting was per-
formed by the method of Towbin et al. [26]. Briefly, the
membrane was blocked in 10% skim milk overnight,
incubated with anti-FLAG M2 (Sigma) for 1 h at room
temperature, followed by incubation with anti-mouse IgG
conjugated with alkaline phosphatase (Sigma) (diluted
1:3000) for 1 h at room temperature. Immunopositive
bands were stained using NBT (Bio-Rad, Hercules, CA,
USA) and BCIP (Bio-Rad).
Results
Sequences of bPRP-VIII and -IX cDNA
Full-length bPRP-VIII and -IX were cloned from bovine
placentome. The 906- and 910-nucleotide sequences were
isolated in bPRP-VIII and -IX, respectively (Fig. 1 and 2).
The protein sequence regions (CDSs) were composed of
711 nucleotides in bPRP-VIII  and 717 nucleotides in
bPRP-IX. The 3'-untranslated region contains one AATAAA
polyadenylation signal start 20 and 26 bases upstream
from the poly (A) addition site in bPRP-VIII and -IX,
respectively. The amino acid sequences deduced from full-
length bPRP-VIII and bPRP-IX cDNA are amino acids 236
and 238. The homology of predicted amino acid
sequences of bPRP-VIII and -IX protein were shown in Fig.
3. The predicted sequence of bPRP-VIII protein was 69%
homologous to that of bPRP-VI, 66% homologous to that
of bPRP-VII, 61% homologous to that of bPRP-I and -III,
58% homologous to that of bPRP-IV and -V, 57% homol-
ogous to that of bPRP-IX, 42% homologous to that of
bPRP-II, and 39% homologous to that of bPL-Ala (Fig. 3).
The predicted sequence of bPRP-IX protein was 81%
homologous to that of bPRP-IV, 76% homologous to that
of bPRP-I, 70% homologous to that of bPRP-II, 60%
homologous to that of bPRP-VII, 57% homologous to
that of bPRP-VI and -VIII, 53% homologous to that of
bPRP-III and -V, and 40% homologous to that of bPL-Ala
(Fig. 3). In the phylogenetic analysis, it was shown that
bPRP-VIII was close to bPRP-III, bPRP-VI, and bPRP-VII
sides in the phylogenetic tree and bPRP-IX was close to
bPRP-II and bPRP-IV sides in the phylogenetic tree (Fig.
4). The N-terminal regions of the bPRP-VIII and -IX pro-
teins were rich in hydrophobic amino acid residue, which
is characteristic of the signal peptide. bPRP-VIII had two
consensus sequences for N-glycosylation and Asn-X-Ser/
Thr at the positions of 60 to 62 and 233 to 235 (Fig. 1).
bPRP-IX also had four consensus sequences for N-glyco-
sylation at the positions of 70 to 72, 92 to 94, 146 to 148,
and 160 to 162 (Fig. 2). Another atypical N-glycosylation
site, Asn-X-Cys was found in only bPRP-IX at the position
of 95 to 97, and this region is identified in bPLs. The TAA
stop codon was used in both bPRP-VIII and -IX, and
appeared after the sequence TGC, which was present in
other bPRPs except for bPRP-VI and bPLs that encode C-
terminal cysteine residue [17]. The predicted 3D struc-
tures of bPRP-VIII and -IX mature region are shown in Fig.
5. The structural differences of N-glycosylation site,
Table 2: Oligonucleotide primers and TaqMan probes used for real-time RT-PCR analysis
Gene Primer or TaqMan probe Sequence Position
bPRP-VIII Forward 5'-CAAGGGTCCTGCCTGCTG-3' 98–115
(AB196438) Reverse 5'-GGCATGTTCTGCCTTGGC-3' 164–344
Probe 5'-TGCTGCTGGTCATGTCAAATCTGCTCC-3' 117–143
bPRP-IX Forward 5'-ATATGCCCAGGGCAAACTGT-3' 287–306
(AB204881) Reverse 5'-TCGGGAGCATGGAAGGAAT-3' 358-340
Probe 5'-TATCAATGCCACCAACAGCTGCCACA-3' 311–336
GAPDH Forward 5'-AAGGCCATCACCATCTTCCA-3' 178–197
(U85042) Reverse 5'-CCACTACATACTCAGCACCAGCAT-3' 253-230
Probe 5'-AGCGAGATCCTGCCAACATCAAGTGG-3' 200–225
TaqMan probes of bPRP-VIII and -IX have 5'-FAM dye and 3'-TAMRA dye
TaqMan probe of GAPDH has 5'-VIC dye and 3'-TAMRA dyeReproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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Nucleotide and deduced amino acid sequences of bPRP-IX Figure 2
Nucleotide and deduced amino acid sequences of bPRP-IX. The arrow indicates the putative primary cleavage site of 
the signal peptide. The potential N-glycosylation site is underlined with a dotted line. The asterisks indicate the termination 
codon. The polyadenylation signal is underlined with a solid line.
                                          1                                      41 
                                          CCAACAGAGAGTCCTCACCCTGCGATCATTCCTCAATCCCC 
    42                                                                          101 
    ATG GCT CCA GCT CCC AAC TTC CAT GGA CAC CAG TGG ACT TAC AAC CCT GTC CGA GGG TCC 
    Met Ala Pro Ala Pro Asn Phe His Gly His Gln Trp Thr Tyr Asn Pro Val Arg Gly Ser 
    1                                                                            20 
    102                                                                         161 
    TGC CTG CTG CTG CTG CTG GTC GTG TCT AAT CTG CTC CTG TGC CAA GGC AAC TCA TGC CCA 
    Cys Leu Leu Leu Leu Leu Val Val Ser Asn Leu Leu Leu Cys Gln Gly Asn Ser Cys Pro 
    21                                                                           40 
162                                                                         221 
    TCC TGT GGT CCT AAC GTG TTT GTC TCC TTA CGG AAA TCC CTT ACA GAC TTG TAT ATT GAT
Ser Cys Gly Pro Asn Val Phe Val Ser Leu Arg Lys Ser Leu Thr Asp Leu Tyr Ile Asp
    41                                                                           60 
    222                                                                         281 
    GCC GCC TGG CTC TCC CAT GAA TTC CAT AAC CTT TCC GCA ATA ATG TTC AGT GAG TTT AAA 
    Ala Ala Trp Leu Ser His Glu Phe His Asn Leu Ser Ala Ile Met Phe Ser Glu Phe Lys 
    61                                                                           80 
    282                                                                         341 
GAA AAA TAT GCC CAG GGC AAA CTG TAC CAT ATC AAT GCC ACC AAC AGC TGC CAC ACC AAT 
    Glu Lys Tyr Ala Gln Gly Lys Leu Tyr His Ile Asn Ala Thr Asn Ser Cys His Thr Asn 
    81                                                                          100 
    342                                                                         401 
    TCC TTC CAT GCT CCC GAA GAA AGA GAT AAA GCC CAC CAG ATG AAT AAT GAA GAC CTT AGT 
    Ser Phe His Ala Pro Glu Glu Arg Asp Lys Ala His Gln Met Asn Asn Glu Asp Leu Ser 
    101                                                                         120 
    402                                                                         461 
    AAG TGG ACA CTT GTG TTA CTG TAC TCC TGG AAT AAT CCT CTG TAT CAT CTA GTC CCG AGG 
    Lys Trp Thr Leu Val Leu Leu Tyr Ser Trp Asn Asn Pro Leu Tyr His Leu Val Pro Arg 
    121                                                                         140 
    462                                                                         521 
    CTT CGG AAT ATG AAA AAT CTG TCA GAG GCT GTC GTA TCA AGT GCC ATG GAG ATT GAG AAC 
    Leu Arg Asn Met Lys Asn Leu Ser Glu Ala Val Val Ser Ser Ala Met Glu Ile Glu Asn
    141                                                                         160 
    522                                                                         581 
    ATG TCA GAC AAA CTT CAG GCA TTC ATA GAG AGT CAA TTC AGG AAG GTT ATT GTT TCA GTC 
    Met Ser Asp Lys Leu Gln Ala Phe Ile Glu Ser Gln Phe Arg Lys Val Ile Val Ser Val 
    161                                                                         180 
    582                                                                         641 
    TTG AAG ACG ATA CAT GAG GCT CGC AGT AGC TGG TCA GGA CTC CCA TCC CTG ACG TCC AGC 
    Leu Lys Thr Ile His Glu Ala Arg Ser Ser Trp Ser Gly Leu Pro Ser Leu Thr Ser Ser 
    181                                                                         200 
    642                                                                         701 
    GAT GAA GAT AGG CGT CTT TCT GAA TTT TAT AAC CTG TTC CAC TGC CTG CAC AGG GAT TCA 
    Asp Glu Asp Arg Arg Leu Ser Glu Phe Tyr Asn Leu Phe His Cys Leu His Arg Asp Ser 
    201                                                                         220 
    702                                                                     758 
    GGG AAA GTT GAC ACG TAC ATC AAG ATC CTG ACG TGC CGA ATC CGC AAA AAG TGC TAA 
    Gly Lys Val Asp Thr Tyr Ile Lys Ile Leu Thr Cys Arg Ile Arg Lys Lys Cys *** 
    221                                                                 238 
    759                                                                         837 
    ATCCACATCCATCCCATCCAGCTCTGAGATGGTCATAATCATCTATCCCATAGCGGGCTACTTGAAATTACAGCTTTTT 
    838                                                                   910
    AATGCATGCTCTGTAATGGGTCTTCTCTTAAAAAATAAACACAGATGGTTTAGAAATGCAAAAAAAAAAAAAAReproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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Comparison of amino acid sequences of bPRP-VIII and -IX with other members of bPRPs and bPLs Figure 3
Comparison of amino acid sequences of bPRP-VIII and -IX with other members of bPRPs and bPLs. Residue 
present in both bPRP-VIII and -IX is shown in black boxes. Residue present in only bPRP-VIII is designated in red boxes. Resi-
due present in only bPRP-IX is designated in green boxes. Amino acid sequences were aligned with assistance from Clustal W 
1.83 on the DDBJ web site. The arrow indicates the putative primary cleavage site of the signal peptide of bPRP-VII. LD1, 2, 3, 
and 4 refer to the conserved domain in the prolactin family.
                1                                                         59
bPRP-VIII MAPAPSFCGHQWTYNPVQGSCLLLLLVMSNLLLCQGRTCPF-CCSDVFDIPLESLRNLFL
bPRP-IX MAPAPNFHGHQWTYNPVRGSCLLLLLVVSNLLLCQGNSCPS-CGPNVFVSLRKSLTDLYI
bPRP-I MAPAPSFRGHQWTYNPVRGSCLLLLLLMSNLLLCQGKSCPS-CGPDVFVSLRKSFTDRFM
bPRP-II         AVGGTHSWSGLLKRVDRREARAQPRLLVLGCLLCQGISCPS-CGPDMFVSLQKSLIDVFI
bPRP-III        -------------------------MVMSNLLLCQVNSCPS-CCPDVFDIPLESLTHLFL
bPRP-IV MAPAPSFRGHQWTYNPVRGSCLLLLLVVSNLLLCQGISCPS-CGPDMFVSLQKSLIDVFI
bPRP-V MAPAPSFHGHQWTYNLVRGSCLLLLLVMSNLLLCQGILCPS-LCPDGDDVCRASLIDLFV
bPRP-VI MAPATSFCGHQWTYNPVRGSCLLLLLVMSNLLLCQGNSCPS-CCPDVSDIPLDLLRELFL
bPRP-VII MAPAPSFHAHQWTYNPVRGSCLLLLLVMSNLLLCQGNSCLC-SRPAVIDIPLESLTVLLL
bPL-Ala MAPASSHRGHQWICDLVRGSCLLLLLVVSNLLLCQGAEDYAPYCKNQPGNCRIPLQSLFE
bPL-Val MAPASSHRGHQWICDLVRGSCLLLLLVVSNLLLCQGVEDYAPYCKNQPGNCRIPLQSLFE
                60 118/119
bPRP-VIII NATMLSRDIAIHSSIMFTDFDEKYAQGKQYDIND-KSCHTDPLPTPEEREQALKINNEDL
bPRP-IX         DAAWLSHEFHNLSAIMFSEFKEKYAQGKLYHINATNSCHTNSFHAPEERDKAHQMNNEDL
bPRP-I NAASLSHDFYNLSTIMFNEFDEKYAQGKLYYINVTKSCHTNSFHAPEERDIVQQTNIEDL
bPRP-II NAASLSHDFHNLSTIMFNEFDEKYAQGKLYYINATKSCHTNSFHTPEERDKAQQMNNEDL
bPRP-III NASRLSHDIVNHTTIMFHEFDEKYAQNQPYTINATKSCHTNSLHTPQEREKALRMNNEDL
bPRP-IV NAASLSHDFHNLSTIMFNEFDEKYAQGKLYYINATKSCHTNSFHTPEERDKAQQMNNEDL
bPRP-V          HASVLSTGMYNHSVKMFTDFDEQYAQGKEYFINVSDKCHTNSLHLPEDMQHIRRMNSKGL
bPRP-VI NATLLSQSILKHSRIMLNEFDEKYAQGKLYYLTATKSCHTNSLHTTEDMDKAEKIDNEDL
bPRP-VII NASRLSHNILKHSRTMFHEFDIKYAQGKLYYINAIKSCHTNSLQTPEEPEKVLETNIKDL
bPL-Ala         RATLVASNNYRLAREMFNEFNKQFGEGKNFTSKFINSCHTEFMTTPNNKEAAANTEDEAL
bPL-Val         RATLVASNNYRLAREMFNEFNKQFGEGKNFTSKVINSCHTEFMTTPNNKEAAANTEDEAL
119/120 178/179
bPRP-VIII SKWIIMLLYSWKRPLNHLVTELQNMKEVSDTILSSARQNLKKVQELQEFIERQFSQIIFP
bPRP-IX SKWTLVLLYSWNNPLYHLVPRLRNMKNLSEAVVSSAMEIENMSDKLQAFIESQFRKVIVS
bPRP-I SKWTLVLLYSWNNPLHHLVTELQHMKELSNAFLSSATRFENMSEKLQAFIERQFSKIIVP
bPRP-II SKWTLVLLYSWNNPLYYLLLELRNMKNLSEAVISSAMEIENMSEKLQAFIESQFRKIIVP
bPRP-III SKWILMLLYSWHRPLYLLVKDLQSMKEVSDTILSSAKENMRKIEELQAFIERQFSQVIYP
bPRP-IV SKWTLVLLYSWNNPLYYLLLELRNMKNLSEAVISSAMEIENMSEKLQAFIESQFRKIIVP
bPRP-V          IMWILMLLYSWQRPLYQLVTDLRSMKEVSNTILSSARENVKKLKELQALIERPFSQVIFT
bPRP-VI SKWILMLLYSWHRPLNHLVTDMRGMIEVSDTILSNAKENVKKVEELQAFIERQFCQIIIP
bPRP-VII SKWILMLLYSWNRPLYHLVTDLRSMKEVSDSIQSNARESVKNLLELQALIERQFCQIIFP
bPL-Ala         LRLVISLLHSWDEPLHQAVTELLHRNGASPDILARAKEIEDKTKVLLEGVE--MIQKRVH
bPL-Val         LRLVISLLHSWDEPLHQAVTELLHRNGASPDILARAKEIEDKTKVLLEGVE--MIQKRVH
179/180 236/238
bPRP-VIII VRR-LTEGEIVWSELPSLVSSDEDIRHSAFYNLFKCLQRDSHKVDMYTKIMLCR-INNTC
bPRP-IX VLKTIHEARSSWSGLPSLTSSDEDRRLSEFYNLFHCLHRDSGKVDTYIKILTCR-IRKKC
bPRP-I VLNTMIQARSSWTGLPSLMSSAEDRRHSEFYNLFYCLRRDSRKVDMYIKILTCR-THKTC
bPRP-II VLKMIHEVSNTWSRFSSMTFSDEDRSISEYYNLFYCLRRDSRKVDMYIKILTCR-TRKTC
bPRP-III VIRTIFKARIYWSGLASLVSNDEDVRHSAFYKLFMCLYRDSRKLDMYTEILACR-ITNTC
bPRP-IV VLKMIHEVSDTWSRFSSMTFSDEDRSISEYYNLFYCLRRDSRKVDMYIKILTCR-TRKTC
bPRP-V          ARRKMYIARIYWFGLRSLLSSNEDRRHSAFYSLFFCLRRDTRKLDIYTKFVACRLIYKKC
bPRP-VI VMRKMLENNIYWSGLPSLLSSDEDVRHSAFYSLFHCLHRDTLEIDIYTKILARRMI-NT-
bPRP-VII VRRKMLKARIYWCGLPSLESSDEDVRHSEFYKLFKCLYRDSRKVDMYTTILGCR-LSNSC
bPL-Ala         PGEKKNEPYPVWSEKSSLTADDEDVRQTAFYRMFHCLHRDSSKISTYINLLKCR--FTPC
bPL-Val         PGEKKNEPYPVWSEKSSLTADDEDVRQTAFYRMFHCLHRDSSKISTYINLLKCR--FTPC
LD1
LD2
LD3 LD4Reproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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disulfide bond (-S-S-) and each atomic configuration were
confirmed. We submitted these sequences to the DNA
Data Bank of Japan (DDBJ). The DDBJ/GenBank acces-
sion Nos. are AB196438 and AB204881.
Expression of bPRP-VIII and -IX mRNA in bovine placenta
The distribution of bPRP-VIII and -IX mRNA was exam-
ined in various bovine tissues by RT-PCR. Both bPRP
mRNAs appeared only in the placental tissue (Fig. 6).
bPRP-VIII and -IX mRNA localization was determined by
in situ hybridization in the bovine placentome on day 60
of gestation (Fig. 7). DIG-labeled bPRP-VIII and -IX anti-
sense RNA probes specifically detected the mRNA tran-
script in the placentome and intercotyledonary mem-
brane. Both bPRPs appeared in the binucleate cells in the
cotyledon and intercotyledonary membrane, and bPRP-IX
mRNA was also detected in trinucleate cells (Figs. 7D and
7F). No significant signals were detected with sense
probes in any genes (Fig. 7B and 7E).
Quantitative real-time RT-PCR analysis indicated that
bPRP-VIII mRNA appeared primarily in the extra-embry-
onic membrane of Day 27, cotyledon and intercotyledon-
ary membrane of Day 60 to 250 (Fig. 8). The expression
intensity increased approximately four-fold in the cotyle-
don from Day 27 to Day 60, and then slightly decreased
until Day 250 (approximately 0.6-fold). The expression
intensity increased approximately three-fold in the inter-
cotyledon from Day 27 to Day 60 and was maintained
from Day 60 to Day 150. Then it then decreased slightly
until Day 250 (approximately 0.7-fold). In the caruncular
area, the expression increased by about four to five times
by Day 60, and the expression level was maintained to late
gestation. However no significant expression was detected
in the intercaruncle. bPRP-IX mRNA was also detected in
the cotyledonary placentome and intercotyledonary
membrane after Day 60 of gestation, but it did not appear
in the extra-embryonic membrane on Day 27 of gestation.
The mRNA expression intensity increased approximately
1.2-fold from Day 60 to Day 150 in the cotyledon and
approximately 1.9-fold the intercotyledon, and then those
values were maintained until Day 250. No expression of
bPRP-IX was observed in the caruncular area on Day 27,
but stable expression intensities were detected from Day
60 to Day 250. These expression intensities were rather
strong compared to the intercotyledonary and cotyledon-
ary areas, even though the sources for this gene may be
binucleate and trinucleate cells.
The recombinant proteins of bPRP-VIII and -IX raised
with HEK293 cell were detected by Western blot analysis
(Fig. 9). The intense bands of bPRP-VIII with a FLAG
epitope tag migrated to approximately 28 kDa molecular
weight, while those of bPRP-IX with a FLAG epitope tag
migrated to 38 kDa, 34 kDa and 26 kDa (Fig. 9).
Discussion
In the present study, we identified two new members of
bPRP cDNAs, bPRP-VIII and -IX. Totally nine bPRP genes
have been identified at this moment in bovine.
bPRP-VIII and -IX cDNA sequences had following features,
respectively. The position of the polyadenylation signal
(AATAAA) in the bPRP-VIII  started 20 bases upstream
from the poly(A) additional site. This configuration is spe-
cific to bPRP-VIII. The number of bases in bPRP-VIII from
the polyadenylation signal to poly(A) site are the fewest in
known bPRPs. The position of the polyadenylation signal
in the bPRP-IX started 26 bases upstream from the poly(A)
additional site. This position coincides with those in
bPRP-II  and  bPRP-IV  [14,15]. The signal peptide
sequences in the N-terminal regions of both bPRP-VIII
and -IX were conserved similarly to those in other bPRPs/
bPLs (Fig. 3). The signal cleavage site was predicted to be
between the Glu-36 and Arg-37 in bPRP-VIII, and
Phylogenetic tree of bPRPs and bPLs Figure 4
Phylogenetic tree of bPRPs and bPLs. The tree was 
constructed using TreeView following alignment of the pro-
tein sequences by the Clustal W 1.83 algorithm. The num-
bers at the base of each branch division represent bootstrap 
values after 1000 repeats. Scale bar represents 0.1 amino 
acid replacements per amino acid site. For GenBank/DDBJ 
accession numbers, refer to Materials and Methods.
bPRP-II
bPRP-IV
bPRP-IX
bPRP-I
bPRP-V
bPRP-VI
bPRP-VIII
bPRP-III
bPRP-VII
bPL-Ala
bPL-Val
0.1
1000
857
998
445
1000
329
128
372
TrichotomyReproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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between Glu-36 and Asn-37 in bPRP-IX by homology to
the N-terminal regions of the bPRPs/bPLs (Fig. 3). As a
result, bPRP-VIII is predicted to be a mature protein com-
posed of 200 amino acids, while bPRP-IX has 202 amino
acids. bPRP-VIII lacked two amino acids (positions 94
and 183), which is a sequence characteristic, since other
known bPRPs have 202 amino acids. bPRP-VIII had two
potential N-glycosylation sites (amino acid portions 60 to
62 and 233 to 235, Figs. 1, 3 and 5). The position of 60 to
62 coincided with those of bPRP-III, -VI, and -VII
[6,14,17], however, the second N-glycosylation site was
found at 233 to 235 in amino acids. In contrast, bPRP-IX
had four potential typical N-glycosylation sites of Asn-X-
Ser/Thr (amino acid portions 70 to 72, 92 to 94, 146 to
148, and 160 to 162, Figs. 2, 3 and 5). All these configu-
rations of Asn-X-Ser/Thr coincide with those of bPRP-II
and -IV [14,15]. However, it is characteristic that only the
bPRP-IX have atypical N-glycosylation site of Asn-X-Cys
(amino acid portions 95 to 97). The conserved domains
(LD1 to LD4, Fig. 3) were suggested by Yamakawa et al.
[15] in other prolactin-related genes. The bPRP-VIII and -
IX sequences also revealed these LD domains. Cysteine
residues (PRP-VIII positions 96, 213, and 230, and PRP-IX
positions 97, 215, and 232) in the LD1 and LD4 domains
were conserved in bPRPs/bPLs, except for bPRP-VI. bPRP-
VIII had four more cysteines (positions 38, 41, 42, and
236, Fig. 3, a total of seven residues in mature protein),
and bPRP-IX had three more cysteines (positions 38, 41,
and 238, Fig. 3, a total of six residues in mature protein).
Expression of bPRP-VIII and -IX mRNA in bovine tissues Figure 6
Expression of bPRP-VIII and -IX mRNA in bovine tis-
sues. Heart, liver, lung, kidney, and spleen were used by RT-
PCR. Cotyledonary tissue at day 148 of gestation was used as 
a placental sample. GAPDH expression in each tissue is pre-
sented as standard data.
bPRP-VIII
GAPDH
Heart
Liver
Lung
Kidney
Spleen
Placenta
bPRP-IX
The predicted 3D structure of (A) bPRP-VIII and (B) bPRP-IX mature protein Figure 5
The predicted 3D structure of (A) bPRP-VIII and (B) bPRP-IX mature protein. The 3D structure were predicted by 
FAMS software. bPRP-VIII structure was able to construct from Cys43 to Cys236 amino acid region. bPRP-IX structure was 
able to construct from Pro40 to Ile234 amino acid region. Disulfide bonds refer to white solid line. Predicted disulfide bonds 
refer to white dot line. N-GLY refer to potential N-glycosylation site.
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These configurations indicate common features in bPRPs/
bPLs. In particular, the configuration of the cysteine resi-
due in bPRP-VIII coincided exactly with that of bPRP-III in
the mature sequence region. The cysteine residue in bPRP-
IX was also the same as that in bPRP-I, -II, and -IV in the
mature sequence region. Therefore, both bPRP-VIII and -
IX may have three disulfide bonds similar to those of
other bPRPs, except for bPRP-VII [6].
The primary mRNA expression of bPRP-VIII and -IX was
observed in the binucleate cells (Fig. 7). Both genes could
independently produce mature recombinant proteins in
the mammalian cell expression system (Fig. 9). The binu-
cleate cells may have produced the bPRP-VIII and -IX pro-
teins simultaneously because bPRP-VIII and -IX mRNA
expressed in the binucleate cells, and HEK293 cells trans-
lated these mRNA to each protein individually. Binucleate
cells are also primary expression cells for bPRP-I and bPL
[27,28] and may have a specific function for implantation
in the fetomaternal interface [11,29]. bPRP-VIII  mRNA
was also expressed in the extra-embryonic membrane just
after the implantation period in the present study (Day 27
of gestation) (Fig. 8). bPRP-VIII may also be related to the
implantation process like bPRP-I and -VII since bPRP-I
was expressed during early gestation. Compare to these
expression, no bPRP-IX was present in the extra-embry-
onic membrane on Day 27 of gestation (Fig. 8). This
mRNA expression pattern implies that bPRP-IX has a dif-
ferent role from bPRP-I and bPL in placental formation
[6]. bPRP-IX mRNA was also detected in the trinucleate
cells. A trinucleate cell is generated by migration of a binu-
cleate cell to an endometrial epithelial cell with the
progress of the pregnancy [30]. bPRP-IX may be a neces-
sary molecule during middle to late gestation. Although
both bPRP-VIII and -IX may be necessary molecules for
gestation, in situ hybridization demonstrated that both
genes were primarily expressed in binucleate and trinucle-
ate cells. This means both genes derive from fetal side ori-
gin, but both were stably contained in the caruncular area
throughout gestation, except bPRP-IX in early gestation.
There are two potential causes of this result. One is con-
tamination after separation. A second possibility is cell
migration [30]. The present study and our previous study
suggest that binucleate and trinucleate cells may migrate
deeply into the endometrium after implantation and
maintain their functions, which may be related to immu-
Localization of bPRP-VIII and -IX in the bovine placentome on day 60 of gestation Figure 7
Localization of bPRP-VIII and -IX in the bovine placentome on day 60 of gestation. (A, B, C) bPRP-VIII and (D, E, F, G) 
bPRP-IX mRNA were detected by in situ hybridization. (A, C, D, F, G) DIG-labeled anti-sense cRNA probes were used. (B, E) 
DIG-labeled sense cRNA probes were used. Seven-microgram sections of bovine placentome were hybridized with each 
probes. Scale bar = 100 µm on the (A, B, D, E) and 20 µm on the (C, F, G).Reproductive Biology and Endocrinology 2005, 3:68 http://www.rbej.com/content/3/1/68
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nomodulation or stress during bovine gestation
[6,7,30,31]. The molecular size of the recombinant pro-
teins completely differed between bPRP-VIII and -IX.
Transcripted bPRP-VIII protein is of relatively smaller size
in the known bPRP family members, and the bPRP-IX
protein is among the largest members [6,32,33]. The sugar
chain addition in post-translational modification will
give large effect in the difference of both molecular
weights. It was found that the predicted 3D structure dif-
fered clearly in both molecules, because configuration of
disulfide bonds and sugar chain addition dynamics are
different. The tertiary structure of bPRP-VIII and -IX are
similar to that of hPRL, so they may share the same recep-
tor. However there is no information and the other evi-
dence may not support this speculation. Only the bPRP-I
gene has been known to produce protein in the placenta,
however, the protein bound to the alpha2-macroglobulin
[32], so it might have a biological function in paracrine
status. Since all other bPRPs have a similar characteristic,
it is difficult to say bPRPs are hormones secreted into cir-
culation from the placenta, such as bPRL and bPL. It was
possible to predict a part of their functions from the
molecular weight, 3D structure, and post-translational
modification. bPRP-VIII and -IX proteins may have differ-
ent functions, since their temporal and special expressions
were different. Various difficulties remain for understand-
ing PRP functions, however, many of the same genes and
molecules are expressed in bovine placenta as in rodent
placenta [7].
Recently, bovine genome projects have addressed various
shotgun sequence data and five known bPRPs, bPL, and
bPRL, a total of seven prolactin related genes, hit in the
NCBI genome database. They are located in Bos taurus
chromosomes 12 and/or 23. bPRP-III, -VII and bPL were
detected on chromosome 23 with bPRL. On the other
hand, bPRP-I, -V, and -VI are placed on chromosome 12.
Rodents such as mice and rats also have various PLPs
[7,34], and they have been clustered on one chromosome,
number 13 in mice and number 17 in rats [34,35]. bPRP-
III and -VII were in comparatively close positions on the
phylogenetic tree in Fig. 4, and they are clustered in the
same chromosome 23. bPRP-VIII may be placed on chro-
mosome 23 because bPRP-VIII was close to bPRP-III or -
VII on the phylogenetic tree, although the bootstrap value
is low between bPRP-VIII and bPRP-III/-VII. bPRP-I, -V,
and -VI, however, were comparatively close on the phylo-
genetic tree in Fig. 4; these genes were clustered on chro-
mosome 12. bPRP-IX may be placed on chromosome 12
because bPRP-IX was close to bPRP-I on the phylogenetic
tree. The actual configuration of the bPRP-VIII and -IX
genome will be addressed in the future. Therefore, prolac-
tin-related genes in mammals may have similar roles for
placental function, but they may evolve through different
phylogenetic processes, may be two separate pathways.
For example, GH and PRL functions are different in vari-
ous species, namely, GH uses the PRL receptor in some
species, but not in others [7,36].
In conclusion, we identified two new members of bPRPs,
bPRP-VIII and -IX. bPRP-VIII was expressed in binucleate
Quantitative real-time RT-PCR analysis of (A) bPRP-VIII and (B) bPRP-IX mRNA in bovine placenta Figure 8
Quantitative real-time RT-PCR analysis of (A) bPRP-VIII and (B) bPRP-IX mRNA in bovine placenta. The total 
RNA was extracted from cotyledons containing extra-embryonic membrane (EEM), cotyledonary placenta (COT), intercotyle-
donary fetal membrane (ICOT), caruncular placenta (CAR), and intercaruncular endometrium (ICAR) on Day 27, Day 60, Day 
150, and Day 250 of gestation. The expressions of these mRNAs were normalized to the expression of GAPDH measured in 
the same RNA preparation. Values are means ± SD. Values with different letters are significantly different (P < 0.05).
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cells in bovine trophoblast tissue and placentome. The
expression appeared as well in bPRP-I, -VII, and bPL, and
it expressed from the implantation period to late in gesta-
tion. bPRP-IX was expressed in binucleate cells and trinu-
cleate cells, and was expressed somewhat late in gestation
compared to other PRPs. These data indicate that various
PRP genes in bovine placenta have coordination roles for
gestation as evidenced in rodents.
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